Cidara Therapeutics
CDTX
CDTX
26 hedge funds and large institutions have $16.9M invested in Cidara Therapeutics in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
48% less funds holding
Funds holding: 50 → 26 (-24)
83% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 29
Holders
26
Holding in Top 10
1
Calls
$104K
Puts
–
Top Buyers
| 1 | +$4.19M | |
| 2 | +$1.74M | |
| 3 | +$158K | |
| 4 |
BlackRock
New York
|
+$152K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$14.7K |
Top Sellers
| 1 | -$1.15M | |
| 2 | -$420K | |
| 3 | -$385K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$291K |
| 5 |
TAM
Tocqueville Asset Management
New York
|
-$150K |